Leukemia, Prolymphocytic, T-Cell
"Leukemia, Prolymphocytic, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lymphoid leukemia characterized by a profound LYMPHOCYTOSIS with or without LYMPHADENOPATHY, hepatosplenomegaly, frequently rapid progression, and short survival. It was formerly called T-cell chronic lymphocytic leukemia.
| Descriptor ID |
D015461
|
| MeSH Number(s) |
C04.557.337.428.565.750 C04.557.337.428.580.125 C15.604.515.560.550.750 C15.604.515.560.575.125 C20.683.515.528.565.750 C20.683.515.528.582.125
|
| Concept/Terms |
Leukemia, Prolymphocytic, T-Cell- Leukemia, Prolymphocytic, T-Cell
- T-Cell Prolymphocytic Leukemia
- Leukemia, T-Cell Prolymphocytic
- Leukemias, T-Cell Prolymphocytic
- Prolymphocytic Leukemia, T-Cell
- Prolymphocytic Leukemias, T-Cell
- T Cell Prolymphocytic Leukemia
- T-Cell Prolymphocytic Leukemias
Leukemia, T Cell, Chronic- Leukemia, T Cell, Chronic
- Leukemia, Lymphocytic, Chronic, T-Cell
- T-Lymphocytic Leukemia, Chronic
- Lymphocytic Leukemia, T Cell, Chronic
- Lymphocytic Leukemia, T-Cell, Chronic
- T-Cell Leukemia, Chronic
- Leukemia, Lymphocytic, Chronic, T Cell
- Leukemia, T-Cell, Chronic
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Prolymphocytic, T-Cell".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Leukemia [C04.557.337]
- Leukemia, Lymphoid [C04.557.337.428]
- Leukemia, Prolymphocytic [C04.557.337.428.565]
- Leukemia, Prolymphocytic, T-Cell [C04.557.337.428.565.750]
- Leukemia, T-Cell [C04.557.337.428.580]
- Leukemia, Prolymphocytic, T-Cell [C04.557.337.428.580.125]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Leukemia, Lymphoid [C15.604.515.560]
- Leukemia, Prolymphocytic [C15.604.515.560.550]
- Leukemia, Prolymphocytic, T-Cell [C15.604.515.560.550.750]
- Leukemia, T-Cell [C15.604.515.560.575]
- Leukemia, Prolymphocytic, T-Cell [C15.604.515.560.575.125]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Leukemia, Lymphoid [C20.683.515.528]
- Leukemia, Prolymphocytic [C20.683.515.528.565]
- Leukemia, Prolymphocytic, T-Cell [C20.683.515.528.565.750]
- Leukemia, T-Cell [C20.683.515.528.582]
- Leukemia, Prolymphocytic, T-Cell [C20.683.515.528.582.125]
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Prolymphocytic, T-Cell".
This graph shows the total number of publications written about "Leukemia, Prolymphocytic, T-Cell" by people in this website by year, and whether "Leukemia, Prolymphocytic, T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Leukemia, Prolymphocytic, T-Cell" by people in Profiles.
-
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance. Leuk Lymphoma. 2019 03; 60(3):649-657.
-
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL. Nat Commun. 2018 02 15; 9(1):697.
-
Broken heart by T-prolymphocytic leukemia. Blood. 2017 08 03; 130(5):691.
-
A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. Br J Haematol. 2018 08; 182(3):429-433.